期刊文献+

下调RALA表达抑制人白血病K562细胞迁移和侵袭

Knockdown of Oncogene RALA Inhibits Migration and Invasion in Leukemia K562 Cells
原文传递
导出
摘要 目的 研究小干扰RNA(siRNA)抑制v-ral 白血病致病因子RALA基因表达对人白血病K562细胞迁移和侵袭的影响.方法 利用LipofectamineTM 2000将化学合成的RALA siRNA转染体外培养的K562细胞,Real-time PCR检测细胞内RALA mRNA的表达水平;Western印迹检测细胞内RALA蛋白的表达水平;Boyden趋化小室实验检测细胞体外迁移和侵袭能力.结果与随机对照组相比,转染48 h后,RALA siRNA显著下调K562细胞内RALA mRNA和蛋白的表达(P<0.05).与随机对照组相比,转染RALA siRNA的K562细胞迁移和侵袭能力显著降低(P<0.05).结论 癌基因RALA在人白血病K562细胞迁移和侵袭过程中发挥重要作用,通过siRNA下调RALA的表达可抑制K562细胞迁移和侵袭能力. Objective To investigate the effect of siRNA-induced v-ral simian leukemia viral oneogene homolog A (RALA) gene down-regulation on cell migration and invasion in human Chron- ic Myelogenous leukemia (CML) K562 cells. Methods The chemically synthesized siRNA targe- ting to RALA gene was transfected into K562 cells using LipofectamineTM 2000. The expression level of RALA mRNA and protein were determined by quantitative real-time PCR and Western blot- ting. The cell migration and invasion was examined by Boyden chamber study. Results Compared with control groups, the results of real-time PCR and Western blotting confirmed successful knock- down of RALA at mRNA and protein levels, respectively (P 〈 0.05 ) . The cell migration and invasion rates were much lower in the siRNA group than in the negative and blank control groups (P 〈 0.05 ) . Conclusion siRNA mediated knockdown of RALA results in the inhibition of migration and invasion in K562 cells. RALA might play an important role in migration of K562 cells.
出处 《医学分子生物学杂志》 CAS CSCD 2011年第6期479-483,共5页 Journal of Medical Molecular Biology
基金 国家自然科学基金(No.81170496)
关键词 v-ral白血病致病因子 小干扰RNA K562细胞 RALA siRNA K562 cells migration invasion
  • 相关文献

参考文献21

  • 1CHARDIN P,TAVITIAN A.The ral gene:a new ras related gene isolated by the use of a synthetic probe[J].EMBO J,1986,5(9):2203-2208.
  • 2PUIL L,LIU J,GISH G,et al.Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway[J].EMBO J,1994,13(4):764-773.
  • 3THOMAS E K,CANCELAS J A,CHAE H D,et al.Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease[J].Cancer Cell,2007,(12):467-478.
  • 4HAMOIS T,CONSTAIN B,RIOUX A,et al.Differential interaction and activation of Rho family GTPases by p210 bcr-abl and p190 bcr-abl[J].Oncogene,2003,22(41):6445-6454.
  • 5SMITH S C,OXFORD G,BARAS A S,et al.Expression of ral GTPases,their effectors,and activators in human bladder cancer[J].Clin Cancer Res,2007,13(13):3803-3813.
  • 6BODEMANN B O,WHITE M A.Ral GTPases and cancer:linchpin support of the tumorigenic platform[J].Nat Rev Cancer,2008,8(2):133-140.
  • 7BEMARDS A.GAPs galore! A.survey of putative Ras superfamily GTPase activating proteins in man and Drosophila[J].Biochim Biophys Acta,2003,1603(2):47-82.
  • 8COLICELLI J.Human RAS superfamily proteins and related GTPases[J].Sci STKE,2004,2004(250):RE13.
  • 9HAMAD N M,ELCONIN J H,KARNOUB A E,et al.Distinct requirements for Ras oncogenesis in human versus mouse cells[J].Genes Dev,2002,16(16):2045-2057.
  • 10RANGARAJIAN A,HONG S J,GIFFORD A,et al.Species-and cell type-specific requirements for cellular transformation[J].Cancer Cell,2004,6(2):171-183.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部